American Journal of Neuroradiology, Vol 4, Issue 3 302-303, Copyright © 1983 by American Society of Neuroradiology
ARTICLES |
Clinical trial of iotrol for lumbar myelography
T Skutta, H Vogelsang, M Galanski, B Hammer and HJ Weinmann
Iotrol, a new nonionic, water-soluble, hexiodinated dimeric contrast medium for myelography, was used in clinical trials in 29 patients. The purpose of the study was to acquire information on local and general tolerance, distribution and excretion, and image quality. Preliminary results show that iotrol is well suited for lumbar and thoracolumbar myelography. Side effects observed with the use of iotrol were fewer and less severe than those reported with metrizamide. Iotrol is cleared from the cerebrospinal fluid and excreted by glomerular filtration within the same time range as other water-soluble contrast media.
This article has been cited by other articles:
 |
|
 |
|
  J. Mizuno, T. Gauss, M. Suzuki, M. Hayashida, H. Arita, and K. Hanaoka Encephalopathy and rhabdomyolysis induced by iotrolan during epiduroscopy: [Encephalopathie et rhabdomyolyse provoquees par l'iotrolan durant l'epiduroscopie] Can J Anesth, January 1, 2007; 54(1): 49 - 53. [Abstract] [Full Text] [PDF]
|
|